title: Vascular endothelial growth factor (VEGF) expression in the lung in toxic septic shock.
abstract: BACKGROUND
  The need for reasoning with medical evidence the different types of shock, especially when there are medical and legal implications, has determined the search of biological markers of the shock. In the case of toxic septic shock, the most important markers to be used are: the cytokines, the tumor necrosis factor-alpha (TNF-alpha) and interleukin 6 (IL-6), procalcitonin, lactoferin and the vascular endothelial growth factor (VEGF). VEGF has an essential role in angiogenesis and vascular permeability.
  
  
  METHODS
  In our study group, we included 30 cases of different types of shock in which we studied the VEGF expression in the lungs. We added also 10 fragments of lung as control group. According to the etiology, the 30 cases of shock were: 15 with a toxic septic shock and 15 with a hemorrhagic shock. In all these cases we used the classical Hematoxylin and Eosin staining method and the immunohistochemical reactions for VEGF-A. Statistical analysis was performed using SPSS 13.0.
  
  
  RESULTS
  The VEGF expression was decreased in all the cases of toxic septic shock, in the endothelium and also in the alveolar epithelium, compared to a high level of expression in other cases of shock and in the control lung.
  
  
  CONCLUSIONS
  These data allow us to appreciate that VEGF has a different expression in different types of shock and in the normal lung. We observed a statistically significant difference between VEGF expression in toxic septic shock and hemorrhagic shock (p=0.000001). There is a similarity of VEGF expression between hemorrhagic shock and the control lungs (p=0.00001). An obviously low VEGF expression in the toxic septic shock represents a useful biological marker in the forensic medical cases.
authors.affiliation: Department of Forensic Medicine, “Grigore T. Popa” University of Medicine and Pharmacy, Iassy, Romania.
authors.forename: Irina
authors.initials: I
authors.lastname: Manoilescu
authors.forename: S
authors.initials: S
authors.lastname: Teleman
authors.forename: Elena
authors.initials: E
authors.lastname: Cojocaru
authors.forename: Doina
authors.initials: D
authors.lastname: Mihăilă
authors.forename: P
authors.initials: P
authors.lastname: Plămădeală
mesh_terms: D016022:Case-Control Studies; D004848:Epithelium / Q000378:metabolism / Q000473:pathology; D006801:Humans; D008168:Lung / Q000378:metabolism* / Q000473:pathology*; D016676:Macrophages, Alveolar / Q000378:metabolism / Q000473:pathology; D011650:Pulmonary Alveoli / Q000378:metabolism / Q000473:pathology; D012772:Shock, Septic / Q000378:metabolism* / Q000473:pathology*; D042461:Vascular Endothelial Growth Factor A / Q000378:metabolism*
chemical_list: C467484:VEGFA protein, human; D042461:Vascular Endothelial Growth Factor A